Helvetica Chimica Acta – Vol. 93 (2010)
903
2’,3’-Di-O-methyladenosine (15) [8 – 10]. A suspension of 60% NaH in oil (1.159 g, 28.98 mmol) in
THF (20 ml) was cooled to 08, treated with a soln. of 14 [7] (6.226 g, 8.28 mmol) in THF (20 ml), and
stirred at 258 for 2.5 h. The mixture was cooled to 08, treated with MeI (1.55 ml, 24.8 mmol), stirred at 258
for 3 h, treated with sat. aq. NH4Cl soln., diluted with H2O, and extracted three times with AcOEt. The
combined org. layers were dried (Na2SO4) and evaporated. The residue was treated with AcOH/H2O 4 :1
(50 ml), stirred for 30 min at 1008, and evaporated. FC (AcOEt/MeOH 9 :1) and recrystallization in
EtOH gave 15 (1.627 g, 67%). White solid. Rf (AcOEt/MeOH 9 :1) 0.13. M.p. 1818 ([8]: 1778). [a]D25
¼
ꢀ120.5 (c ¼ 0.55, CHCl3; [8]: ꢀ 49). UV (CHCl3): 261 (14680). IR (ATR): 3362m, 3264m, 3230m,
3108m, 2988w, 2921m, 2832w, 2747w, 2692w, 1683s, 1611s, 1567m, 1514w, 1475m, 1422m, 1387m, 1343m,
1325w, 1289s, 1216m, 1186m, 1173w, 1114s, 1095s, 1076s, 1048s, 1021m, 977m, 952m, 911w, 879w, 815w.
1H-NMR (300 MHz, CDCl3): see Table 5; additionally, 6.81 (dd, J ¼ 12.0, 1.9, HOꢀC(5’)); 5.74 (br. s,
NH2); 3.54, 3.33 (2s, 2 MeO). 13C-NMR (75 MHz, CDCl3): see Table 6; additionally, 58.60, 58.04 (2q,
2 MeO). HR-MALDI-MS: 296.1353 ([M þ H]þ, C12H18N5O4þ ; calc. 296.1359). Anal. calc. for
C12H17N5O4 (295.30): C 48.81, H 5.80, N 23.72; found: C 48.84, H 5.81, N 23.42.
N6-Benzoyl-5’-O-[dimethyl(1,1,2-trimethylpropyl)silyl]-2’,3’-di-O-methyladenosine (16). A soln. of
15 (2.879 g, 9.75 mmol) in pyridine (45 ml) at 08 was treated with TDSCl (2.49 ml, 12.68 mmol), stirred at
258 for 7.5 h, and treated with two additional portions of TDSCl (2 ꢃ 1.3 ml, 13.2 mmol) over 24 h. The
soln. was cooled to 08, treated with BzCl (5.7 ml, 48.8 mmol), and stirred at 258 for 13 h. The mixture was
cooled to 08, treated with H2O (20 ml) and 25% NH3 · H2O soln. (40 ml), stirred for 30 min at 08, and
evaporated. A soln. of the residue in AcOEt was washed with aq. 0.01m HCl and sat. aq. NaHCO3 soln.
The org. layer was dried (Na2SO4) and evaporated. FC (CH2Cl2/MeOH 95 :5) gave 16 (4.399 g, 83%).
White solid. Rf (CH2Cl2/MeOH 95 :5) 0.38. M.p. 608 (sintering from 458). [a]2D5 ¼ ꢀ13.6 (c ¼ 0.9, CHCl3).
UV (CHCl3): 280 (21670). IR (ATR): 3252w, 3125w, 3059w, 2955m, 2865w, 2830w, 1698m, 1608s, 1580s,
1509m, 1482m, 1451s, 1405w, 1390w, 1377w, 1326m, 1290m, 1248s, 1220s, 1189m, 1124s, 1094s, 1074s,
1048m, 1030m, 998m, 983m, 876m, 824m. 1H-NMR (300 MHz, CDCl3): see Table 5; additionally, 9.20 (br.
s, NH); 8.00 – 7.98 (m, 2 arom. H); 7.59 – 7.46 (m, 3 arom. H); 3.57, 3.44 (2s, 2 MeO); 1.64 (sept., J ¼ 6.8,
Me2CH); 0.88 (d, J ¼ 6.8, Me2CH); 0.88 (s, Me2CSi); 0.16, 0.15 (2s, Me2Si). 13C-NMR (75 MHz, CDCl3):
see Table 6; additionally, 164.77 (s, C¼O); 133.89 (s); 132.76 (d); 128.89 (2d); 127.94 (2d); 58.70, 58.19
(2q, 2 MeO); 34.15 (d, Me2CH); 25.53 (s, Me2CSi); 20.48, 20.40 (2q, Me2CSi); 18.64, 18.56 (2q, Me2CH);
ꢀ 3.24, ꢀ 3.46 (2q, Me2Si). HR-MALDI-MS: 542.2800 ([M þ H]þ, C27H40N5O5Siþ; calc. 542.2799).
N6-Benzoyl-5’-O-[dimethyl(1,1,2-trimethylpropyl)silyl]-8-(hydroxymethyl)-2’,3’-di-O-methyladeno-
sine (17). A soln. of (i-Pr)2NH (4.85 ml, 37.0 mmol) in THF (25 ml) at 08 was treated dropwise with 1.6m
BuLi in hexane (23.1 ml, 37.0 mmol), stirred for 40 min at 08, cooled to ꢀ 788, treated dropwise with a
soln. of 16 (4.006 g, 7.40 mmol) in THF (25 ml), stirred for 2 h at ꢀ 788, treated dropwise with DMF
(14.3 ml, 185 mmol), stirred for 3 h, treated with AcOH (6.4 ml, 111 mmol), and allowed to warm to 258.
The mixture was diluted with EtOH (30 ml), cooled to 08, treated portionwise with NaBH4 (840 mg,
22.2 mmol), stirred for 30 min at 08, treated with sat. aq. NH4Cl soln. and H2O, and extracted three times
with AcOEt. The combined org. layers were washed three times with sat. aq. NH4Cl soln., dried
(Na2SO4), and evaporated. FC (CH2Cl2/MeOH 95 :5) gave 17 (3.134 g, 74%). A sample for analysis was
recrystallized in MeCN. White solid. Rf (CH2Cl2/MeOH 95 :5) 0.23. M.p. 1478. [a]2D5 ¼ ꢀ34.9 (c ¼ 0.8,
CHCl3). UV (CHCl3): 283 (21380). IR (ATR): 3410w (sh.), 3233w, 3204w, 2955m, 2933m, 2868w, 2831w,
1698s, 1614s, 1583m, 1527m, 1505m, 1488m, 1461m, 1438m, 1344m (sh.), 1330m, 1301w, 1249s, 1209w,
1121s, 1071s, 998m, 986m, 966w, 937w, 899w, 875w, 828s. 1H-NMR (300 MHz, CDCl3): see Table 5;
additionally, 9.12 (br. s, NH); 8.04 – 8.02 (m, 2 arom. H); 7.62 – 7.50 (m, 3 arom. H); 4.24 (t, J ¼ 6.3, OH);
3.52, 3.43 (2s, 2 MeO); 1.59 (sept., J ¼ 6.9, Me2CH); 0.85 (d, J ¼ 6.9, Me2CH); 0.81 (s, Me2CSi); 0.08, 0.06
(2s, Me2Si). 13C-NMR (75 MHz, CDCl3): see Table 6; additionally, 164.88 (s, C¼O); 133.88 (s); 132.84
(d); 128.96 (2d); 128.02 (2d); 58.58, 58.14 (2q, 2 MeO); 34.23 (d, Me2CH); 25.37 (s, Me2CSi); 20.38, 20.34
(2q, Me2CSi); 18.61 (q, Me2CH); ꢀ 3.37, ꢀ 3.42 (2q, Me2Si). HR-MALDI-MS: 572.2904 ([M þ H]þ,
C28H42N5O6Siþ; calc. 572.2897). Anal. calc. for C28H41N5O6Si (571.75): C 58.82, H 7.23, N 12.25; found: C
58.91, H 7.04, N 12.12.
N6-Benzoyl-8-(chloromethyl)-5’-O-[dimethyl(1,1,2-trimethylpropyl)silyl]-2’,3’-di-O-methyladenosine
(18). A soln. of 17 (1.892 g, 3.31 mmol) in CH2Cl2 (16 ml) at 08 was treated with EtN(i-Pr)2 (866 ml,
4.97 mmol) and MsCl (256 ml, 3.31 mmol), stirred at 258 for 24 h, treated with LiCl (140 mg, 3.31 mmol),